Rivaroxaban Versus Warfarin for Thromboprophylaxis in Children With Giant Coronary Artery Aneurysms After Kawasaki Disease: a Multicenter, Open-label, Parallel, Exploratory, Randomized Controlled Trial
Latest Information Update: 21 Feb 2025
At a glance
- Drugs Rivaroxaban (Primary) ; Aspirin; Clopidogrel; Warfarin
- Indications Thrombosis
- Focus Therapeutic Use
Most Recent Events
- 14 Feb 2025 Planned initiation date changed from 1 Dec 2024 to 1 Jul 2025.
- 09 Jul 2024 Planned End Date changed from 1 Jun 2025 to 1 Sep 2027.
- 09 Jul 2024 Planned primary completion date changed from 1 Jan 2025 to 1 Jun 2027.